<DOC>
	<DOCNO>NCT00304226</DOCNO>
	<brief_summary>The population current study include stage 1 stage 2 hypertensive patient newly diagnose n't treatment last 3 month patient currently treat uncontrolled present monotherapy . The purpose study evaluate efficacy treatment valsartan versus treatment amlodipine reach blood pressure control 14 week treatment .</brief_summary>
	<brief_title>Effectiveness Valsartan Based Versus Amlodipine Based Treatment Strategy naïve Patients With Stage 1 Stage 2 Hypertension Patients Uncontrolled Current Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion Stage/grade 1 stage/ grade 2 hypertension , MSSBP ≥ 140 mm Hg , and/ MSDBP ≥ 90 mm Hg , Visit 1 2 untreated patient Or Patients currently treat monotherapy uncontrolled blood pressure ≤ 160/100 mm Hg Visit 1 Visit 2 Exclusion criterion Current treatment CCB MSSBP ≥ 180 mm Hg MSDBP ≥ 110 mm Hg time visit 1 Visit 2 History hypersensitivity study drug drug similar chemical structure Evidence secondary form hypertension Cerebrovascular accident myocardial infarction last 12 month , prior Visit 1 Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Valsartan ,</keyword>
	<keyword>amlodipine ,</keyword>
	<keyword>hydrochlorothiazide</keyword>
</DOC>